SA
IMCR logo
Immunocore Holdings plc(IMCR)
Closing price · checked 8:40 PM ETAbout this dataData status
$27.51▼-0.30 (-1.08%)
Extended:$27.51+0.00 (+0.00%)· 8:40 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average (VIX 24.6)

Overview →

Immunocore Holdings plc (IMCR)

R&D to Revenue

68.71%

Fiscal year · Period ending:

IMCR logo

IMCR R&D to Revenue

Latest reported68.71%
IMCR FY R&D/Revenue (319.72% → 68.71%)
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

IMCR r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunocore Holdings plc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
68.7145%
71.5534%
65.568%
58.454%
274.7725%
248.4193%
389.5399%
353.3229%
423.3446%
279.5082%
193.1143%
191.3337%
319.717%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.